Academic institution

Global Genomics Market Report 2023: Sector is Expected to Reach $411.35 Billion by 2030 at a CAGR of 19.4% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 12, 2023

The global genomics market size was valued at USD 27.81 billion in 2021 and is poised to grow from USD 33.25 billion in 2022 to USD 411.35 billion by 2030, growing at a CAGR of 19.4% in the forecast period (2023-2030).

Key Points: 
  • The global genomics market size was valued at USD 27.81 billion in 2021 and is poised to grow from USD 33.25 billion in 2022 to USD 411.35 billion by 2030, growing at a CAGR of 19.4% in the forecast period (2023-2030).
  • Government funding for genomics efforts has increased as a result of the rising incidence of cancer worldwide.
  • Global Genomics Market is segmented based on Deliverables, Technology, End Use, application, and Region.
  • The growth of Next-Generation Sequencing (NGS), which is increasingly being employed in cancer research, is driving the global genomics market.

Global ADME-Toxicology Testing Analysis Report 2023-2030: Increased Need to Check Late-Stage Drug Failures Drive Market Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 29, 2023

North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth

Key Points: 
  • North America and Europe Dominate, Asia-Pacific Witnesses Rapid Growth
    Steady Increase in Average Drug Development Cost and Efforts to Mitigate Late-Stage Drug Failure Rates Highlights the Role of ADME-Toxicology Testing: Average Cost of Drug Development (in US$ Billion) in the US since 1980s
    actors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others
    Drug Withdrawals Due to Toxicity Issues (1990-early 2010s): Percentage Share Breakdown of Number of Drugs Withdrawn Due to Cardiotoxicity, Hepatotoxicity and Others
    World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America
    Growth Momentum Shifts Away from In Vivo Technologies; In Vitro Technologies to Lead the Charge
    Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services
    Global Market for Cell-based Assays by End-User (2020): Percentage Share Breakdown of Value Sales for Pharma & Biotech Companies, Government & Academic Institutes, CROs, and Others
    World Cell-based Assays Market by Application (2020): Percentage Breakdown of Revenue for ADME, Basic Research and Drug Discovery
    Personalized Treatments & Computational Tools: Intriguing Facets of ADME R&D ADME Pharmacogenomics to Power Personalized Treatments

Antimicrobial Susceptibility Testing Market - Global Forecasts to 2030 - Clinical Diagnostics Segment to Dominate the $5.98 Billion Market - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 22, 2023

The "Antimicrobial Susceptibility Testing Market: Global Industry Analysis, Trends, Size, Share and Forecasts to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antimicrobial Susceptibility Testing Market: Global Industry Analysis, Trends, Size, Share and Forecasts to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global antimicrobial susceptibility testing market provides qualitative and quantitative analysis for the period from 2021-2030.
  • The global antimicrobial susceptibility testing market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America.
  • Complete coverage of all the segments in the antimicrobial susceptibility testing market to analyze the trends, developments in the global market, and forecast of market size up to 2030.

Biopsy Devices Market Predicted to Achieve Striking Growth of USD 3.96 Billion with Healthy CAGR of 7.3% by 2029, Size, Share, Trends, Demand and Competitive Analysis

Retrieved on: 
Tuesday, March 7, 2023

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...

Key Points: 
  • To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biopsy-devices...
    North America Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-biopsy-de...
    Europe Biopsy Devices Market , By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and other Products), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Mri-Guided Biopsy and Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), and Country https://www.databridgemarketresearch.com/reports/europe-biopsy-devices-m...
    Asia-Pacific Biopsy Devices Market By Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires and Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Other Guidance Techniques), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Other Applications), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/asia-pacific-biopsy-dev...
    Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other) https://www.databridgemarketresearch.com/reports/global-breast-biopsy-de...
    North America Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems and Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization and Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy and Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Other), and Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-breast-bi...
    Europe Breast Biopsy Devices Market , By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), Type (Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy, Other Biomarkers), Guidance (Image-Guided Biopsy, Liquid Biopsy, Other Guidance Techniques), Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), Country https://www.databridgemarketresearch.com/reports/europe-breast-biopsy-de...
    Asia-Pacific Breast Biopsy Devices Market , By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other), Country https://www.databridgemarketresearch.com/reports/asia-pacific-breast-bio...
    Smart Biopsy Devices Market , By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Others), Product (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products), Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers) Country https://www.databridgemarketresearch.com/reports/global-smart-biopsy-dev...
    Vacuum Assisted Biopsy Devices Market , By Product (Vacuum-assisted Biopsy Systems, Vacuum-assisted Biopsy Needles), Type (9-12G, 12G), Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, Others), Applications (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others) https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Endobronchial Ultrasound Biopsy Devices Market , By Product (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Trans bronchial Aspiration Needles, Spray Catheters, Others), Application (Cancer Diagnosis, Infection Diagnosis, Others), Country https://www.databridgemarketresearch.com/reports/global-endobronchial-ul...
    Liquid Biopsy Market , By Sampling Type (Blood Sampling Liquid Biopsy, Urine Sampling Liquid Biopsy and Saliva and Other Tissue Fluids Sampling Liquid Biopsy), Products and Service (Assays Kits, Instruments and Services), Circulating Biomarker (Circulating Tumour Cells, Circulating Tumour DNA (CTDNA), Cell-Free DNA, Extracellular Vesicles (EVS) and Other Circulating Biomarkers), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring and Recurrence Monitoring), Application (Cancer Applications and Non-Cancer Applications), End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centres and Other End Users) https://www.databridgemarketresearch.com/reports/global-liquid-biopsy-ma...
    Breast Cancer Liquid Biopsy Market , By Product (Consumables, Kits), Circulating Biomarkers (Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), ctRNA, Circulating Tumor Cells (CTCs), cfRNA, Others), End Users (Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories), Country https://www.databridgemarketresearch.com/reports/global-breast-cancer-li...
    Core Needle Biopsy Market , By Type (Full-Automated Core Needle Biopsy Device and Semi-Automated Core Needle Biopsy Device), Applications (Hospitals, Clinics and Others), Disease (Lung Cancer, Liver Cancer, Breast Cancer and Prostate Cancer), Range (14G- 18G, 18G), Distribution Channel (Direct Sales and Distributor), Country https://www.databridgemarketresearch.com/reports/global-core-needle-biop...
    Image-Guided Biopsy Market , By Technology (X- Ray, Ultrasound, Mammograpy, CT, MRI), Process (Fine Needle, Core Needle, Vacuum- Assisted Biopsy), End-User (Hospitals, Ambulatory Surgery Centers, Clinics, Research and Academic Institutes), Country https://www.databridgemarketresearch.com/reports/global-image-guided-bio...
    Vacuum-Assisted Biopsy Market By Guiding Technique (Stereotactic Vacuum Assist Biopsy System and Image Guided Vacuum Assist Biopsy System), Type (9-12G, 12G), Applications (Hospitals, Academic and Research Institutes and Diagnostics and Imaging Centres), Country https://www.databridgemarketresearch.com/reports/global-vacuum-assisted-...
    Needle Biopsy Market , By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales), Country https://www.databridgemarketresearch.com/reports/global-needle-biopsy-ma...
    Biopsy Forceps Market , By Type (Rigid Biopsy Forceps, Flexible Biopsy Forceps), Product Type (Cupped Jaws Biopsy Forceps, Oval Ring Jaws Biopsy Forceps, Radial Jaw Biopsy Forceps, Others), Usability (Disposable Biopsy Forceps, Reusable Biopsy Forceps), Application (Laparoscopy, Hysterectomy, Hysteroscopy, Others), End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-forceps-m...
    Biopsy Guns and Needles Market , By Product Type (Disposable, Reusable), Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers, Others), Country https://www.databridgemarketresearch.com/reports/global-biopsy-guns-and-...

Antimicrobial Susceptibility Testing Market worth $4.7 billion | MarketsandMarkets

Retrieved on: 
Wednesday, March 1, 2023

Based on the product type, the antimicrobial susceptibility testing market is segmented into Manual antimicrobial susceptibility testing products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables.

Key Points: 
  • Based on the product type, the antimicrobial susceptibility testing market is segmented into Manual antimicrobial susceptibility testing products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables.
  • North America accounted for the largest share of 35.4% of the antimicrobial susceptibility testing market in 2022.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=206359984
    Antimicrobial Susceptibility Testing Market Advantages:
    Antimicrobial susceptibility testing (AST) is a laboratory technique used to determine the susceptibility or resistance of microorganisms to antimicrobial drugs.
  • Here are some advantages of the antimicrobial susceptibility testing market:
    Accurate Diagnosis: Antimicrobial susceptibility testing provides accurate and reliable results for the diagnosis of bacterial infections.

Antimicrobial Susceptibility Testing Market worth $4.7 billion | MarketsandMarkets

Retrieved on: 
Wednesday, March 1, 2023

Based on the product type, the antimicrobial susceptibility testing market is segmented into Manual antimicrobial susceptibility testing products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables.

Key Points: 
  • Based on the product type, the antimicrobial susceptibility testing market is segmented into Manual antimicrobial susceptibility testing products, Automated Laboratory Instruments, Culture and Growth Media, and Consumables.
  • North America accounted for the largest share of 35.4% of the antimicrobial susceptibility testing market in 2022.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=206359984
    Antimicrobial Susceptibility Testing Market Advantages:
    Antimicrobial susceptibility testing (AST) is a laboratory technique used to determine the susceptibility or resistance of microorganisms to antimicrobial drugs.
  • Here are some advantages of the antimicrobial susceptibility testing market:
    Accurate Diagnosis: Antimicrobial susceptibility testing provides accurate and reliable results for the diagnosis of bacterial infections.

Blockchain Technology in Healthcare Market Report 2023: Viability for Secure Data Storage and Exchange Boosts Adoption - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 31, 2023

This report features an extensive study of the current market landscape and future potential of blockchain in drug discovery and clinical trials.

Key Points: 
  • This report features an extensive study of the current market landscape and future potential of blockchain in drug discovery and clinical trials.
  • The technology has the potential to revolutionize the healthcare sector as it has emerged as a viable option to store / exchange data within the healthcare industry.
  • What is the Current Market Landscape of the Blockchain Market Focused on Drug Discovery and Clinical Trials?
  • Question 3: Which segment, in terms of type of blockchain, dominates the blockchain market focusing on drug discovery and clinical trials?

Global Capillary Electrophoresis Strategic Business Report 2022: Featuring Agilent Technologies, Bio-Rad Laboratories, Danaher and Helena Laboratories Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023

The "Capillary Electrophoresis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Capillary Electrophoresis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • Academic Institutes & CROs, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$614.7 Million by the end of the analysis period.
  • In the global Other End-Use segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment.
  • Latin America will expand at a 4.8% CAGR through the analysis period.

Minimal Residual Disease Testing Global Market Report 2022: Industry to Reach $2.3 Billion by 2027 at a 14% CAGR - ResearchAndMarkets.com

Retrieved on: 
Friday, December 30, 2022

The global minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period.

Key Points: 
  • The global minimal residual disease testing market is valued at an estimated USD 1.2 Billion in 2022 and is projected to reach USD 2.3 Billion by 2027, at a CAGR of 14.0% during the forecast period.
  • The PCR segment accounted for the highest growth rate in the minimal residual disease testing market, by technology, during the forecast period
    The minimal residual disease testing market is segmented into flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS).
  • In 2021, the PCR segment accounted for the highest growth rate in the minimal residual disease testing market.
  • The global minimal residual disease testing market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World.

Global Point-of-Care Molecular Diagnostics Market Report 2022-2027: Growing Popularity of mHealth for Allergy Diagnosis Increases Affordability - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 29, 2022

Increasing Prevalence of Infectious Diseases, Hospital-Acquired Infections (HAIs), and Cancer

Key Points: 
  • Increasing Prevalence of Infectious Diseases, Hospital-Acquired Infections (HAIs), and Cancer
    The Global Point-of-Care Molecular Diagnostics Market is segmented based on Product, Technology, Applications, End-Users, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Point-of-Care Molecular Diagnostics Market.
  • The analyst analyses the Global Point-of-Care Molecular Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Point-of-Care Molecular Diagnostics Market.